article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

article thumbnail

Bormioli Pharma Invents: pioneering a connected future in pharmaceutical packaging

Digital Health Global

In the ever-evolving landscape of pharmaceuticals, innovation has become a guiding force for companies toward a future where healthcare is not only effective but seamlessly integrated into our daily lives. The company envisions a future where connected devices enhance patient care and pharmaceutical packaging simultaneously.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

The pharmaceutical landscape is undergoing a momentous transformation, marked by the convergence of cutting-edge technologies that are redefining every aspect of the industry. The first application of AI to the pharmaceutical industry is its use in ramping up and improving new drug discovery.

article thumbnail

Aptar Digital Health Announces Acquisition of Healint to Reinforce Digital Health Portfolio and Drive Future Growth

Digital Health Global

The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment. CRYSTAL LAKE, Ill.–(BUSINESS

article thumbnail

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Digital Health Global

(Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).

article thumbnail

blueBriX digital health platform expands into pharmaceutical sector

DigitalHealth

Digital health platform blueBriX is expanding into the pharma sector, supporting the use of software as a medical device to drive patient experience.

article thumbnail

Pharmaceutical Multinationals Continue To Spurn The Opportunity To Connect Via Social Media At A Local Level

Digital Health Global

The Report shows that the world’s leading pharmaceutical companies continue to spurn the opportunity to connect via social media at a local level. Roche Pharmaceuticals 3. Bayer (Pharmaceuticals Division) 4. Pfizer, Janssen, Novartis, Novo Nordisk, AbbVie and Takeda Pharmaceutical have at least 11 local apps available.